Northeast Pharmaceutical Group Co Ltd (000597) — Cash Flow Quality Index
Northeast Pharmaceutical Group Co Ltd (000597) has a Cash Flow Quality Index of 6.30x as of September 2025. Operating cash flow of CN¥274.09 Million exceeds net income of CN¥43.52 Million, indicating high earnings quality where cash backs reported profits. Explore Northeast Pharmaceutical Group Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Northeast Pharmaceutical Group Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Northeast Pharmaceutical Group Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Northeast Pharmaceutical Group Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Northeast Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Northeast Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see 000597 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.25x | CN¥1.11 Billion | CN¥260.07 Million | ▲ +129.8% |
| 2024 | 1.85x | CN¥758.76 Million | CN¥409.85 Million | ▲ +13.1% |
| 2023 | 1.64x | CN¥586.75 Million | CN¥358.46 Million | ▼ -47.3% |
| 2022 | 3.10x | CN¥1.11 Billion | CN¥357.05 Million | ▼ -60.3% |
| 2021 | 7.82x | CN¥746.51 Million | CN¥95.44 Million | ▼ -85.2% |
| 2020 | 52.73x | CN¥570.92 Million | CN¥10.83 Million | ▲ +2448.8% |
| 2019 | 2.07x | CN¥352.60 Million | CN¥170.44 Million | ▲ +46.1% |
| 2018 | 1.42x | CN¥285.09 Million | CN¥201.37 Million | ▲ +143.3% |
| 2017 | -3.27x | CN¥-301.20 Million | CN¥92.06 Million | ▼ -122.4% |
| 2016 | 14.60x | CN¥384.51 Million | CN¥26.35 Million | ▲ +2503.4% |
| 2014 | 0.56x | CN¥46.99 Million | CN¥83.82 Million | ▼ -92.1% |
| 2012 | 7.05x | CN¥86.09 Million | CN¥12.21 Million | ▲ +57.8% |
| 2010 | 4.47x | CN¥255.96 Million | CN¥57.27 Million | ▲ +245.5% |
| 2009 | 1.29x | CN¥615.91 Million | CN¥476.08 Million | ▼ -34.7% |
| 2008 | 1.98x | CN¥709.03 Million | CN¥357.94 Million | ▼ -53.1% |
| 2007 | 4.23x | CN¥198.56 Million | CN¥46.99 Million | ▲ +178.2% |
| 2006 | -5.40x | CN¥-106.00 Million | CN¥19.63 Million | ▼ -164.7% |
| 2005 | 8.34x | CN¥111.40 Million | CN¥13.35 Million | ▼ -67.9% |
| 2004 | 25.96x | CN¥211.06 Million | CN¥8.13 Million | ▼ -2.3% |
| 2003 | 26.57x | CN¥230.08 Million | CN¥8.66 Million | ▲ +72.0% |
| 2002 | 15.45x | CN¥157.41 Million | CN¥10.19 Million | ▲ +98.1% |
| 2001 | 7.80x | CN¥78.84 Million | CN¥10.11 Million | ▲ +522.4% |
| 2000 | 1.25x | CN¥36.13 Million | CN¥28.84 Million | ▼ -0.5% |
| 1999 | 1.26x | CN¥54.62 Million | CN¥43.38 Million | ▲ +1233.2% |
| 1998 | -0.11x | CN¥-7.59 Million | CN¥68.35 Million | — |